Drug
HDM1002 clinical trials
Also written HDM1002.
- studies test it
- 10
- open now
- 9
- in phase 3
- 3
- first study started
- 2024
Keep track of what changes. Save the HDM1002 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2024 (5)
| Year | Studies |
|---|---|
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 2
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Repaglinide (1) · Atorvastatin (1) · Digoxin (1) · Rosuvastatin (1) · Metformin (1) · Empagliflozin (1) · Midazolam (1) · Valsartan (1)
Studies
Open first, then newest update. How each study uses HDM1002 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy SubjectsRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07594847Written as HDM1002 200 mg
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07331389Written as HDM1002
- Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07193459Written as HDM1002 200 mg
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07082114Written as HDM1002 100 mg
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNot yet recruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06885021Written as HDM1002 200mg, oral, once daily, 52 weeks
- A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy SubjectsNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06608329Written as HDM1002
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06601517Written as HDM1002
- HDM1002 Tablets in Chinese Overweight and Obese Adult SubjectsNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06520540Written as HDM1002 100 mg QD 12weeks
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNot yet recruitingPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06500299Written as HDM1002 100 mg QD
- To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusCompletedPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06481085Written as HDM1002 50 mg